Explore our news page for thought leadership articles, technical expertise and the latest developments in the world of innovation funding.
Filter
Hooke Biotechnology have secured €5.5m in blended finance from the highly competitive Horizon Europe EIC Accelerator to develop Mera.
The Grants team at Myriad Associates are proud to announce that they have secured over €30m from the Disruptive Technologies Innovation Fund (DTIF).
Onkimmune was founded in 2015 with the goal of developing novel anti-cancer therapies using Natural Killer (NK) cells.
Myriad Associates is proud to announce that 4 of our clients who applied for the Disruptive Technologies Innovation Fund were all approved on Monday 10th December.